INTRODUCTION
The aetiology and outcome of abdominal pain in individuals with sickle cell disorder (SCD) vary from patient to patient. Abdominal pain may be due to a definite pathology within the abdomen e.g. peptic ulcer disease, 1 cholelithiasis, [2] [3] [4] [5] cholecystitis, 6 viral hepatitis [7] [8] [9] [10] and other infective processes or it may be due to pain referred from elsewhere such as the lungs, ribs, spine and hips. When abdominal pain is not due to any specific intra-abdominal pathology in sickle cell patients, it is termed abdominal painful crisis resulting from vasoocclusive effects of mesenteric arterial 11, 12 or portal vein thrombosis. 13 The aetiology of abdominal pain in the sickle cell patient is multifactorial. Most of the previous studies have been predominantly in children and adolescents. The prevalence of these aetiological factors and the interaction between certain clinical features in adult patients have not been extensively reported.
MATERIALS AND METHODS
Medical records of adults with Hb SS or Hb SC attending the Haematology Outpatients' Clinic of the Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, over a ten-year period (1996) (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) were reviewed. Obafemi Awolowo University Teaching Hospitals Complex is located in southwestern Nigeria and provides health care services to people from the five states that surround it and to those that have been referred from other parts of Nigeria. It is a 600-bedded hospital located in a town with a population of about 750,000. Southwestern Nigeria is in the rain forest where malaria is endemic and the language of the indigenes is Yoruba.
Information with respect to the following was obtained: demographic data; haemoglobin electrophoresis pattern; frequency of vaso-occlusive crisis (VOC) per year; frequency of abdominal pain per year, location and character of abdominal pain; liver and spleen size in the steady state and packed cell volume (PCV). Data were analyzed using means and standard deviations (SD); Student's t-test; Chi-squared test; and correlations. P-values = 0.05 were considered statistically significant.
RESULTS
A total of 154 patients were reviewed and observed to have a mean age of 22.8 ± 7.7 years and M: F ratio of 1:1. 
Frequency of Abdominal Pain
The frequency of abdominal pain as documented in 38(76%) patients with Hb SS and 6(75%) with Hb SC is shown in while burning or peppery pain occurred in 11(22%) Hb SS and three (37.5%) Hb SC patients. Colicky abdominal pain occurred in seven (14%) Hb SS and two (25%) Hb SC patients, while pain was nonspecific in 10(20%) Hb SS and one (12.5%) Hb SC patients. Table 2 shows that the epigastrium was the commonest site of abdominal pain in 18 (36%) Hb SS and four (50%) Hb SC patients, followed by a diffuse/generalized location which occurred in 14(28%) and one (12.5%) of Hb SS and Hb SC patients respectively. The site was unknown in 12(24%) of Hb SS and three (37.5%) of Hb SC patients. Hypochrondrial and suprapubic pain did not occur in Hb SC patients. The 11 patients with Hb SS who had abdominal VOC all presented with dull, diffuse/ generalized abdominal pain and one had colicky pain in addition. Dull pain due to abdominal VOC accounted for 61% of all Table 1 . Of these, 31(81.6%) Hb SS patients and all the six patients with Hb SC had less than five episodes per year.
•
The frequency of abdominal pain per year in Hb SS patients was not different from that of Hb SC patients (p > 0.05). However, 14% of Hb SS, but none of the Hb SC patients, had more than four episodes of abdominal pain per year and in 25% of patients from each group the frequency of abdominal pain was unknown. Figure 1 shows the frequency of the character of the abdominal pain experienced by the patients. Abdominal pain was predominantly dull in 18(36%) Hb SS and two (25%) Hb SC patients, (17.2%) patients, 11 (22%) had pain and 11 (14.1%) did not have pain. Analysis of the same clinical features in Hb SC patients showed that those with or without abdominal pain had a mean PCV of 30.3 ± 4.6% and 28.6 ± 3.5% respectively; liver size was not palpable (0 cm) and 7.0 ± 1.7 cm respectively; and spleen size was 7.0 cm and 5.8 ± 2.1 cm respectively ( Table 3) . The number of patients in these sub-groups was too small to assess significance of gender variation in PCV. Hepatomegaly occurred in three (15.4%), all three had abdominal pain and splenomegaly occurred in five (19.2%) patients, one (12.5%) had pain and four (22.2%) did not. The population size for these sub-groups was too small to be subjected to statistical analysis. The steady state PCV decreased with increasing liver size in Hb SS patients and the correlation was stronger in patients without abdominal pain than those with pain (r = -0.37; p < 0.001 and -0.30) respectively. Table 4 shows the aetiology of abdominal pain in both Hb SS and Hb SC patients. In SCA these included peptic ulcer disease (PUD) in 14 (28%); abdominal VOC in 11 (26%); hepatopathy in five (10%); enteritis in three (6%); cholelithiasis in three (6%); menstruationrelated pain in two (4%) being 8% of Hb SS female patients; and other diagnoses such as splenic abscess, appendicitis and cystitis for example. In Hb SC patients, PUD occurred in four (50%) of cases, enteritis in two (25%); hepatopathy in one (12.5%); and multiple splenic abscess in one (12.5%). Pains due to abdominal VOC and cholelithiasis did not occur in these patients and neither was menstruation-related pain observed in the four female Hb SC patients. The 11 Hb SS patients with abdominal VOC had a mean PCV of 22.6 ± 2.3%. Seven (63.6%) of them had no organomegaly, whilst two (18.2%) had hepatosplenomegaly. These data are similar to those of patients without abdominal pain.
Character and Location of Abdominal Pain

Aetiology of Abdominal Pain
Mode of Management and Outcome
Majority of patients with either Hb SS (68%) or SC (75%) were treated as outpatients in the day ward. The rates of hospital admission for abdominal pain in SCD were similar in both groups of patients (p > 0.05). All patients in this study with abdominal pain recovered with the exception of an Hb SC patient who had multiple splenic abscesses.
DISCUSSION
The study population consisted mainly of young adults who dominated the sickle cell clinic. The prevalence rate and pattern of abdominal pain in Hb SS patients mirrored that of Hb SC patients (although HbSC patients were fewer). The frequency of abdominal pain in this study was similar to that obtained among Ghanaian patients, 14 in whom it occurred in one of three patients with HbSS and one of four patients with Hb SC. Abdominal pain was predominantly dull in HbSS patients and occurred more in the epigastrium in both groups of patients, suggesting PUD or gastritis. This was confirmed by endoscopy in a few patients and the frequent use of nonsteriodal anti-inflammatory drugs (NSAIDs) for pain management was implicated. This observation is similar to that of Lee et al 1 but contrary to the Ghanaian study 14 that reported the prevalence rate of PUD to be 2% and the most common location of pain was generalized in both Hb SS and Hb SC patients alike. Further studies are needed to confirm the aetiology of epigastric pain in this cohort of patients.
Abdominal VOC occurred in 25% Hb SS patients, but in none of the Hb SC patients. Since Hb SC patients have a milder illness than Hb SS patients, this cases of dull abdominal pain in Hb SS patients and the diffuse/generalized location accounted for 78.6% of such location in the same group of patients.
Associated Clinical Features in the Steady State
In the steady state of 50 (39.1%) Hb SS patients with pain and the 78 patients (60.9%) without pain the PCV (22.7 ± 3.0% and 23.2 ± 3.7% respectively), liver size (8.1 ± 4.7 cm and 8.1 ± 4.3 cm respectively) and spleen size (6.5 ± 3.1cm and 9.9 ± 6.4 cm respectively) did not vary significantly (Table 3) . Generally there was no gender variation in the PCV of these patients (22.7 ± 3.4% and 22.7 ± 2.6% for males and females respectively). Hepatomegaly occurred in 45 (35.2%) patients, 18 (36%) had pain and 27 (34.6%) did not have pain. Splenomegaly occurred in 22 The prevalence rate obtained in this study may be higher if asymptomatic patients (without abdominal pain) were included after abdominal ultrasonography to rule in or rule out cholilethiasis.
The PCV in the steady state was significantly higher among patients with Hb SC than Hb SS as expected (p < 0.01), but it was unable to distinguish between patients with or without abdominal pain in the two groups (p > 0.05). The PCV was also unable to distinguish those who had abdominal VOC from those with other causes of abdominal pain. There was no sex variation in the PCV values for males and females with Hb SS contrary to observations among individuals with Hb AA or AS. The presence of hepatomegaly was more unlikely to be related to abdominal pain in both groups of patients, but splenomegaly however tended to be equally prevalent in both Hb SS and Hb SC patients with or without pain. The size of the liver and the spleen, in the steady state of Hb SS patients, did not distinguish between those who developed abdominal pain from those who did not. The import of a stronger inverse correlation between the PCV and the size of the liver in Hb SS patients without abdominal pain is not clear, because there was no significant difference in the mean values for PCV and the liver size for both groups of patients in this study.
All patients with abdominal pain recovered with the exception of an Hb SC patient who had multiple abscesses in the spleen and died of overwhelming sepsis.
CONCLUSION
The prevalence rate and pattern of abdominal pain appear to be similar in Hb SS and Hb SC patients. The epigastrium was the commonest location and PUD/ gastritis was the commonest cause in both Hb SS and Hb SC patients and chronic use of NSAIDs has been implicated. Abdominal VOC occurred in 25% Hb SS patients but in none of the Hb SC patients and may therefore be a marker of disease severity. The PCV, liver and spleen size in the steady state do not appear to be predictors of abdominal pain or abdominal VOC in this cohort of patients, but dull and diffuse/generalised pain is more likely to be associated with abdominal VOC than any other aetiology. The outcome of management is generally good.
